表纸
市场调查报告书
商品编码
1092273

聚合酵素的全球市场,成果与预测(2017年~2028年)

Global Polymerases Market Report, History and Forecast 2017-2028

出版日期: | 出版商: QYResearch | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

  • 全貌
  • 简介
  • 目录
简介

全球聚合酵素的市场规模,2021年是3亿4,592万美金。

该市场,预计在预测期间(2022年~2028年)时5.9%的年复合成长率发展,至2028年达到5亿2,294万美元。

全球主要制造商为Thermo Fisher Scientific,Merck,New England Biolabs,Promega,Illumina,Agilent Technologies,F. Hoffmann-la Roche,Takara Bio,QIAGEN N.V.等,在2021年,6家主要企业占约84.33%的收益占有率。

本报告提供全球聚合酵素市场相关调查,市场规模和预测,市场区隔、各地区的市场分析,市场动态,竞争情形,主要企业的简介等资讯。

目录

第1章 聚合酵素市场概要

  • 聚合酵素的产品概要
  • 各类型:市场区隔
    • DNA聚合酵素
    • RNA聚合酵素
  • 各类型:全球市场规模
    • 市场规模概要(2017-2028)
    • 市场规模成果检讨(2017-2022)
    • 市场规模预测(2023-2028)
  • 各类型:主要地区的市场规模市场区隔
    • 北美的销售明细译(2017-2022)
    • 欧洲的销售明细译(2017-2022)
    • 亚太地区的销售明细译(2017-2022)
    • 南美的销售明细译(2017-2022)
    • 中东、非洲的销售明细译(2017-2022)

第2章 各企业:市场竞争

  • 各销售:全球主要企业(2017-2022)
  • 各收益:全球主要企业(2017-2022)
  • 各价格:全球主要企业(2017-2022)
  • 市场竞争情形和趋势
  • 各企业类型(TIER 1,TIER 2,TIER 3):全球主要制造商(2021年时刻的收益基于)
  • 主要制造商的市场进入日
  • 主要制造商的提供产品
  • 合并和收购,扩大

第3章 各地区:聚合酵素的现况与展望

  • 各地区:全球市场规模和年复合成长率(2017 VS 2021 VS 2028)
  • 各地区:全球市场规模成果
  • 各地区:全球市场规模预测

第4章 各用途:聚合酵素

  • 各用途:市场区隔
    • 学术、研究机关
    • 医院、诊断中心
    • 制药、生物科技企业
  • 各用途:全球市场规模
    • 市场规模概要(2017-2028)
    • 市场规模成果检讨(2017-2022)
    • 市场规模预测(2023-2028)
  • 各用途:主要地区的市场规模市场区隔
    • 北美的销售明细译(2017-2022)
    • 欧洲的销售明细译(2017-2022)
    • 亚太地区的销售明细译(2017-2022)
    • 南美的销售明细译(2017-2022)
    • 中东、非洲的销售明细译(2017-2022)

第5章 各国:北美的聚合酵素

  • 市场规模成果
  • 市场规模预测

第6章 各国:欧洲的聚合酵素

  • 市场规模成果
  • 市场规模预测

第7章 各地区:亚太地区的聚合酵素

  • 市场规模成果
  • 市场规模预测

第8章 各国:南美的聚合酵素

  • 市场规模成果
  • 市场规模预测

第9章 各国:中东、非洲的聚合酵素

  • 市场规模成果
  • 市场规模预测

第10章 聚合酵素事业的企业简介与主要资料

  • THERMO FISHER SCIENTIFIC
  • MERCK
  • NEW ENGLAND BIOLABS
  • PROMEGA
  • AMPLIQON
  • AGILENT TECHNOLOGIES
  • F. HOFFMANN-LA ROCHE
  • TAKARA BIO
  • QIAGEN NV
  • BIOCHAIN INSTITUTE
  • ENZO BIOCHEM
  • ABBEXA
  • BIONEER
  • KANEKA
  • NIPPON GENE

第11章 上游产业,机会,课题,风险,及影响要素分析

  • 主要原料
  • 制造成本结构
  • 产业链分析

第12章 行销策略分析,分销商

  • 销售频道
  • 分销商
  • 下游客户

第13章 调查结果结论

第14章 附录

目录

Market Analysis and Insights:

Due to the COVID-19 pandemic, the global Polymerases market size was value at US$ 345.92 million in 2021 and is forecast to be a readjusted size of US$ 522.94 million by 2028 with a CAGR of 5.9% during the forecast period 2022-2028.

The global main manufacturers of Polymerases include Thermo Fisher Scientific, Merck, New England Biolabs, Promega, Illumina, Agilent Technologies, F. Hoffmann-la Roche, Takara Bio, and QIAGEN N.V., etc. In 2021, the global six largest players have a share approximately 84.33% in terms of revenue.

The North America Polymerases market size was US$ 123.61 million in 2021, while China was about US$ 51.70 million. The proportion of the China was 14.95% in 2021 and it is predicted that the share will reach 16.72% in 2028. As for the Europe Polymerases landscape, Germany is projected to reach US$ 38.61 million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is 5.14% and 1.69% respectively for the next 6-year period.

Fully considering the economic change by the COVID-19, DNA Polymerases accounting for 74.61% of the Polymerases global market in 2021, is projected to value US$ 391.26 million by 2028, growing at a revised 6.0% CAGR from 2022 to 2028. While Academic & Research Institutes segment is altered to a 6.3% CAGR throughout this forecast period and will hold a share about 49.96% in 2028.

Scope and Market Size:

The global Polymerases market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Polymerases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.

By Company

  • Thermo Fisher Scientific
  • Merck
  • New England Biolabs
  • Promega
  • Ampliqon
  • Agilent Technologies
  • F. Hoffmann-la Roche
  • Takara Bio
  • QIAGEN N.V.
  • BioChain Institute
  • Enzo Biochem
  • Abbexa
  • Bioneer
  • Kaneka
  • NIPPON GENE

Segment by Type

  • DNA Polymerases
  • RNA Polymerases

Segment by Application

  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • Korea
    • India
    • Southeast Asia
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Russia
    • Italy
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE

TABLE OF CONTENTS

1 POLYMERASES MARKET OVERVIEW

  • 1.1 POLYMERASES PRODUCT OVERVIEW
  • 1.2 POLYMERASES MARKET SEGMENT BY TYPE
    • 1.2.1 DNA POLYMERASES
    • 1.2.2 RNA POLYMERASES
  • 1.3 GLOBAL POLYMERASES MARKET SIZE BY TYPE
    • 1.3.1 GLOBAL POLYMERASES MARKET SIZE OVERVIEW BY TYPE (2017-2028)
    • 1.3.2 GLOBAL POLYMERASES HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022)
    • 1.3.3 GLOBAL POLYMERASES FORECASTED MARKET SIZE BY TYPE (2023-2028)
  • 1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE
    • 1.4.1 NORTH AMERICA POLYMERASES SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.2 EUROPE POLYMERASES SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.3 ASIA-PACIFIC POLYMERASES SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.4 LATIN AMERICA POLYMERASES SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.5 MIDDLE EAST AND AFRICA POLYMERASES SALES BREAKDOWN BY TYPE (2017-2022)

2 POLYMERASES MARKET COMPETITION BY COMPANY

  • 2.1 GLOBAL TOP PLAYERS BY POLYMERASES SALES (2017-2022)
  • 2.2 GLOBAL TOP PLAYERS BY POLYMERASES REVENUE (2017-2022)
  • 2.3 GLOBAL TOP PLAYERS BY POLYMERASES PRICE (2017-2022)
  • 2.4 POLYMERASES MARKET COMPETITIVE SITUATION AND TRENDS
    • 2.4.1 POLYMERASES MARKET CONCENTRATION RATE (2017-2022)
    • 2.4.2 GLOBAL 3 AND 5 LARGEST MANUFACTURERS BY POLYMERASES SALES AND REVENUE IN 2021
  • 2.5 GLOBAL TOP MANUFACTURERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN POLYMERASES AS OF 2021)
  • 2.6 DATE OF KEY MANUFACTURERS ENTER INTO POLYMERASES MARKET
  • 2.7 KEY MANUFACTURERS POLYMERASES PRODUCT OFFERED
  • 2.8 MERGERS & ACQUISITIONS, EXPANSION

3 POLYMERASES STATUS AND OUTLOOK BY REGION

  • 3.1 GLOBAL POLYMERASES MARKET SIZE AND CAGR BY REGION: 2017 VS 2021 VS 2028
  • 3.2 GLOBAL POLYMERASES HISTORIC MARKET SIZE BY REGION
    • 3.2.1 GLOBAL POLYMERASES SALES IN VOLUME BY REGION (2017-2022)
    • 3.2.2 GLOBAL POLYMERASES SALES IN VALUE BY REGION (2017-2022)
    • 3.2.3 GLOBAL POLYMERASES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2017-2022)
  • 3.3 GLOBAL POLYMERASES FORECASTED MARKET SIZE BY REGION
    • 3.3.1 GLOBAL POLYMERASES SALES IN VOLUME BY REGION (2023-2028)
    • 3.3.2 GLOBAL POLYMERASES SALES IN VALUE BY REGION (2023-2028)
    • 3.3.3 GLOBAL POLYMERASES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2023-2028)

4 POLYMERASES BY APPLICATION

  • 4.1 POLYMERASES MARKET SEGMENT BY APPLICATION
    • 4.1.1 ACADEMIC & RESEARCH INSTITUTES
    • 4.1.2 HOSPITALS & DIAGNOSTIC CENTERS
    • 4.1.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 4.2 GLOBAL POLYMERASES MARKET SIZE BY APPLICATION
    • 4.2.1 GLOBAL POLYMERASES MARKET SIZE OVERVIEW BY APPLICATION (2017-2028)
    • 4.2.2 GLOBAL POLYMERASES HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022)
    • 4.2.3 GLOBAL POLYMERASES FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
  • 4.3 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION
    • 4.3.1 NORTH AMERICA POLYMERASES SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.3.2 EUROPE POLYMERASES SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.3.3 ASIA-PACIFIC POLYMERASES SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.3.4 LATIN AMERICA POLYMERASES SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.3.5 MIDDLE EAST AND AFRICA POLYMERASES SALES BREAKDOWN BY APPLICATION (2017-2022)

5 NORTH AMERICA POLYMERASES BY COUNTRY

  • 5.1 NORTH AMERICA POLYMERASES HISTORIC MARKET SIZE BY COUNTRY
    • 5.1.1 NORTH AMERICA POLYMERASES SALES IN VOLUME BY COUNTRY (2017-2022)
    • 5.1.2 NORTH AMERICA POLYMERASES SALES IN VALUE BY COUNTRY (2017-2022)
  • 5.2 NORTH AMERICA POLYMERASES FORECASTED MARKET SIZE BY COUNTRY
    • 5.2.1 NORTH AMERICA POLYMERASES SALES IN VOLUME BY COUNTRY (2023-2028)
    • 5.2.2 NORTH AMERICA POLYMERASES SALES IN VALUE BY COUNTRY (2023-2028)

6 EUROPE POLYMERASES BY COUNTRY

  • 6.1 EUROPE POLYMERASES HISTORIC MARKET SIZE BY COUNTRY
    • 6.1.1 EUROPE POLYMERASES SALES IN VOLUME BY COUNTRY (2017-2022)
    • 6.1.2 EUROPE POLYMERASES SALES IN VALUE BY COUNTRY (2017-2022)
  • 6.2 EUROPE POLYMERASES FORECASTED MARKET SIZE BY COUNTRY
    • 6.2.1 EUROPE POLYMERASES SALES IN VOLUME BY COUNTRY (2023-2028)
    • 6.2.2 EUROPE POLYMERASES SALES IN VALUE BY COUNTRY (2023-2028)

7 ASIA-PACIFIC POLYMERASES BY REGION

  • 7.1 ASIA-PACIFIC POLYMERASES HISTORIC MARKET SIZE BY REGION
    • 7.1.1 ASIA-PACIFIC POLYMERASES SALES IN VOLUME BY REGION (2017-2022)
    • 7.1.2 ASIA-PACIFIC POLYMERASES SALES IN VALUE BY REGION (2017-2022)
  • 7.2 ASIA-PACIFIC POLYMERASES FORECASTED MARKET SIZE BY REGION
    • 7.2.1 ASIA-PACIFIC POLYMERASES SALES IN VOLUME BY REGION (2023-2028)
    • 7.2.2 ASIA-PACIFIC POLYMERASES SALES IN VALUE BY REGION (2023-2028)

8 LATIN AMERICA POLYMERASES BY COUNTRY

  • 8.1 LATIN AMERICA POLYMERASES HISTORIC MARKET SIZE BY COUNTRY
    • 8.1.1 LATIN AMERICA POLYMERASES SALES IN VOLUME BY COUNTRY (2017-2022)
    • 8.1.2 LATIN AMERICA POLYMERASES SALES IN VALUE BY COUNTRY (2017-2022)
  • 8.2 LATIN AMERICA POLYMERASES FORECASTED MARKET SIZE BY COUNTRY
    • 8.2.1 LATIN AMERICA POLYMERASES SALES IN VOLUME BY COUNTRY (2023-2028)
    • 8.2.2 LATIN AMERICA POLYMERASES SALES IN VALUE BY COUNTRY (2023-2028)

9 MIDDLE EAST AND AFRICA POLYMERASES BY COUNTRY

  • 9.1 MIDDLE EAST AND AFRICA POLYMERASES HISTORIC MARKET SIZE BY COUNTRY
    • 9.1.1 MIDDLE EAST AND AFRICA POLYMERASES SALES IN VOLUME BY COUNTRY (2017-2022)
    • 9.1.2 MIDDLE EAST AND AFRICA POLYMERASES SALES IN VALUE BY COUNTRY (2017-2022)
  • 9.2 MIDDLE EAST AND AFRICA POLYMERASES FORECASTED MARKET SIZE BY COUNTRY
    • 9.2.1 MIDDLE EAST AND AFRICA POLYMERASES SALES IN VOLUME BY COUNTRY (2023-2028)
    • 9.2.2 MIDDLE EAST AND AFRICA POLYMERASES SALES IN VALUE BY COUNTRY (2023-2028)

10 COMPANY PROFILES AND KEY FIGURES IN POLYMERASES BUSINESS

  • 10.1 THERMO FISHER SCIENTIFIC
    • 10.1.1 THERMO FISHER SCIENTIFIC CORPORATION INFORMATION
    • 10.1.2 THERMO FISHER SCIENTIFIC INTRODUCTION AND BUSINESS OVERVIEW
    • 10.1.3 THERMO FISHER SCIENTIFIC POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.1.4 THERMO FISHER SCIENTIFIC POLYMERASES PRODUCTS OFFERED
    • 10.1.5 THERMO FISHER SCIENTIFIC RECENT DEVELOPMENT
  • 10.2 MERCK
    • 10.2.1 MERCK CORPORATION INFORMATION
    • 10.2.2 MERCK INTRODUCTION AND BUSINESS OVERVIEW
    • 10.2.3 MERCK POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.2.4 MERCK POLYMERASES PRODUCTS OFFERED
    • 10.2.5 MERCK RECENT DEVELOPMENT
  • 10.3 NEW ENGLAND BIOLABS
    • 10.3.1 NEW ENGLAND BIOLABS CORPORATION INFORMATION
    • 10.3.2 NEW ENGLAND BIOLABS INTRODUCTION AND BUSINESS OVERVIEW
    • 10.3.3 NEW ENGLAND BIOLABS POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.3.4 NEW ENGLAND BIOLABS POLYMERASES PRODUCTS OFFERED
    • 10.3.5 NEW ENGLAND BIOLABS RECENT DEVELOPMENT
  • 10.4 PROMEGA
    • 10.4.1 PROMEGA CORPORATION INFORMATION
    • 10.4.2 PROMEGA INTRODUCTION AND BUSINESS OVERVIEW
    • 10.4.3 PROMEGA POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.4.4 PROMEGA POLYMERASES PRODUCTS OFFERED
  • 10.5 AMPLIQON
    • 10.5.1 AMPLIQON CORPORATION INFORMATION
    • 10.5.2 AMPLIQON INTRODUCTION AND BUSINESS OVERVIEW
    • 10.5.3 AMPLIQON POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.5.4 AMPLIQON POLYMERASES PRODUCTS OFFERED
  • 10.6 AGILENT TECHNOLOGIES
    • 10.6.1 AGILENT TECHNOLOGIES CORPORATION INFORMATION
    • 10.6.2 AGILENT TECHNOLOGIES INTRODUCTION AND BUSINESS OVERVIEW
    • 10.6.3 AGILENT TECHNOLOGIES POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.6.4 AGILENT TECHNOLOGIES POLYMERASES PRODUCTS OFFERED
    • 10.6.5 AGILENT TECHNOLOGIES RECENT DEVELOPMENT
  • 10.7 F. HOFFMANN-LA ROCHE
    • 10.7.1 F. HOFFMANN-LA ROCHE CORPORATION INFORMATION
    • 10.7.2 F. HOFFMANN-LA ROCHE INTRODUCTION AND BUSINESS OVERVIEW
    • 10.7.3 F. HOFFMANN-LA ROCHE POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.7.4 F. HOFFMANN-LA ROCHE POLYMERASES PRODUCTS OFFERED
    • 10.7.5 F. HOFFMANN-LA ROCHE RECENT DEVELOPMENT
  • 10.8 TAKARA BIO
    • 10.8.1 TAKARA BIO CORPORATION INFORMATION
    • 10.8.2 TAKARA BIO INTRODUCTION AND BUSINESS OVERVIEW
    • 10.8.3 TAKARA BIO POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.8.4 TAKARA BIO POLYMERASES PRODUCTS OFFERED
  • 10.9 QIAGEN N.V.
    • 10.9.1 QIAGEN N.V. CORPORATION INFORMATION
    • 10.9.2 QIAGEN N.V. INTRODUCTION AND BUSINESS OVERVIEW
    • 10.9.3 QIAGEN N.V. POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.9.4 QIAGEN N.V. POLYMERASES PRODUCTS OFFERED
  • 10.10 BIOCHAIN INSTITUTE
    • 10.10.1 BIOCHAIN INSTITUTE CORPORATION INFORMATION
    • 10.10.2 BIOCHAIN INSTITUTE INTRODUCTION AND BUSINESS OVERVIEW
    • 10.10.3 BIOCHAIN INSTITUTE POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.10.4 BIOCHAIN INSTITUTE POLYMERASES PRODUCTS OFFERED
  • 10.11 ENZO BIOCHEM
    • 10.11.1 ENZO BIOCHEM CORPORATION INFORMATION
    • 10.11.2 ENZO BIOCHEM INTRODUCTION AND BUSINESS OVERVIEW
    • 10.11.3 ENZO BIOCHEM POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.11.4 ENZO BIOCHEM POLYMERASES PRODUCTS OFFERED
  • 10.12 ABBEXA
    • 10.12.1 ABBEXA CORPORATION INFORMATION
    • 10.12.2 ABBEXA INTRODUCTION AND BUSINESS OVERVIEW
    • 10.12.3 ABBEXA POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.12.4 ABBEXA POLYMERASES PRODUCTS OFFERED
  • 10.13 BIONEER
    • 10.13.1 BIONEER CORPORATION INFORMATION
    • 10.13.2 BIONEER INTRODUCTION AND BUSINESS OVERVIEW
    • 10.13.3 BIONEER POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.13.4 BIONEER POLYMERASES PRODUCTS OFFERED
  • 10.14 KANEKA
    • 10.14.1 KANEKA CORPORATION INFORMATION
    • 10.14.2 KANEKA INTRODUCTION AND BUSINESS OVERVIEW
    • 10.14.3 KANEKA POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.14.4 KANEKA POLYMERASES PRODUCTS OFFERED
  • 10.15 NIPPON GENE
    • 10.15.1 NIPPON GENE CORPORATION INFORMATION
    • 10.15.2 NIPPON GENE INTRODUCTION AND BUSINESS OVERVIEW
    • 10.15.3 NIPPON GENE POLYMERASES SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 10.15.4 NIPPON GENE POLYMERASES PRODUCTS OFFERED

11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

  • 11.1 POLYMERASES KEY RAW MATERIALS
    • 11.1.1 KEY RAW MATERIALS
    • 11.1.2 RAW MATERIALS KEY SUPPLIERS
  • 11.2 MANUFACTURING COST STRUCTURE
    • 11.2.1 RAW MATERIALS
    • 11.2.2 LABOR COST
    • 11.2.3 MANUFACTURING EXPENSES
  • 11.3 POLYMERASES INDUSTRIAL CHAIN ANALYSIS

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS

  • 12.1 SALES CHANNEL
  • 12.2 POLYMERASES DISTRIBUTORS
  • 12.3 POLYMERASES DOWNSTREAM CUSTOMERS

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

  • 14.1 RESEARCH METHODOLOGY
    • 14.1.1 METHODOLOGY/RESEARCH APPROACH
    • 14.1.2 DATA SOURCE
  • 14.2 AUTHOR DETAILS
  • 14.3 DISCLAIMER 115

LIST OF TABLES

  • Table 1. Major Company of DNA Polymerases
  • Table 2. Major Company of RNA Polymerases
  • Table 3. Global Polymerases Sales by Type: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 4. Global Polymerases Sales by Type (2017-2022) & (M Units)
  • Table 5. Global Polymerases Sales Market Share in Volume by Type (2017-2022)
  • Table 6. Global Polymerases Sales by Type (2017-2022) & (US$ Million)
  • Table 7. Global Polymerases Sales Market Share in Value by Type (2017-2022)
  • Table 8. Global Polymerases Price by Type (2017-2022) & (USD/Unit)
  • Table 9. Global Polymerases Sales by Type (2023-2028) & (M Units)
  • Table 10. Global Polymerases Sales Market Share in Volume by Type (2023-2028)
  • Table 11. Global Polymerases Sales by Type (2023-2028) & (US$ Million)
  • Table 12. Global Polymerases Sales Market Share in Value by Type (2023-2028)
  • Table 13. Global Polymerases Price by Type (2023-2028) & (USD/Unit)
  • Table 14. North America Polymerases Sales by Type (2017-2022) & (M Units)
  • Table 15. North America Polymerases Sales by Type (2017-2022) & (US$ Million)
  • Table 16. Europe Polymerases Sales (M Units) by Type (2017-2022)
  • Table 17. Europe Polymerases Sales by Type (2017-2022) & (US$ Million)
  • Table 18. Asia-Pacific Polymerases Sales (M Units) by Type (2017-2022)
  • Table 19. Asia-Pacific Polymerases Sales by Type (2017-2022) & (US$ Million)
  • Table 20. Latin America Polymerases Sales (M Units) by Type (2017-2022)
  • Table 21. Latin America Polymerases Sales by Type (2017-2022) & (US$ Million)
  • Table 22. Middle East and Africa Polymerases Sales (M Units) by Type (2017-2022)
  • Table 23. Middle East and Africa Polymerases Sales by Type (2017-2022) & (US$ Million)
  • Table 24. Global Polymerases Sales by Company (2017-2022) & (M Units)
  • Table 25. Global Polymerases Sales Share by Company (2017-2022)
  • Table 26. Global Polymerases Revenue by Company (2017-2022) & (US$ Million)
  • Table 27. Global Polymerases Revenue Share by Company (2017-2022)
  • Table 28. Global Market Polymerases Price by Company (2017-2022) & (USD/Unit)
  • Table 29. Global Polymerases Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymerases as of 2021)
  • Table 31. Date of Key Manufacturers Enter into Polymerases Market
  • Table 32. Key Manufacturers Polymerases Product Type
  • Table 33. Mergers & Acquisitions, Expansion Plans
  • Table 34. Global Polymerases Market Size Comparison by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 35. Global Polymerases Sales by Region (2017-2022) & (M Units)
  • Table 36. Global Polymerases Sales Market Share in Volume by Region (2017-2022)
  • Table 37. Global Polymerases Sales by Region (2017-2022) & (US$ Million)
  • Table 38. Global Polymerases Sales Market Share in Value by Region (2017-2022)
  • Table 39. Global Polymerases Sales (M Units), Value (US$ Million) and Price (USD/Unit)
  • Table 40. Global Polymerases Sales by Region (2023-2028) & (M Units)
  • Table 41. Global Polymerases Sales Market Share in Volume by Region (2023-2028)
  • Table 42. Global Polymerases Sales by Region (2023-2028) & (US$ Million)
  • Table 43. Global Polymerases Sales Market Share in Value by Region (2023-2028)
  • Table 44. Global Polymerases Sales (M Units), Value (US$ Million) and Price (USD/Unit)
  • Table 45. Global Polymerases Sales by Application: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 46. Global Polymerases Sales by Application (2017-2022) & (M Units)
  • Table 47. Global Polymerases Sales Market Share in Volume by Application (2017-2022)
  • Table 48. Global Polymerases Sales by Application (2017-2022) & (US$ Million)
  • Table 49. Global Polymerases Sales Market Share in Value by Application (2017-2022)
  • Table 50. Global Polymerases Price by Application (2017-2022) & (USD/Unit)
  • Table 51. Global Polymerases Sales by Application (2023-2028) & (M Units)
  • Table 52. Global Polymerases Sales Market Share in Volume by Application (2023-2028)
  • Table 53. Global Polymerases Sales by Application (2023-2028) & (US$ Million)
  • Table 54. Global Polymerases Sales Market Share in Value by Application (2023-2028)
  • Table 55. Global Polymerases Price by Application (2023-2028) & (USD/Unit)
  • Table 56. North America Polymerases Sales by Application (2017-2022) & (M Units)
  • Table 57. North America Polymerases Sales by Application (2017-2022) & (US$ Million)
  • Table 58. Europe Polymerases Sales (M Units) by Application (2017-2022)
  • Table 59. Europe Polymerases Sales by Application (2017-2022) & (US$ Million)
  • Table 60. Asia-Pacific Polymerases Sales (M Units) by Application (2017-2022)
  • Table 61. Asia-Pacific Polymerases Sales by Application (2017-2022) & (US$ Million)
  • Table 62. Latin America Polymerases Sales (M Units) by Application (2017-2022)
  • Table 63. Latin America Polymerases Sales by Application (2017-2022) & (US$ Million)
  • Table 64. Middle East and Africa Polymerases Sales (M Units) by Application (2017-2022)
  • Table 65. Middle East and Africa Polymerases Sales by Application (2017-2022) & (US$ Million)
  • Table 66. North America Polymerases Sales by Country (2017-2022) & (M Units)
  • Table 67. North America Polymerases Sales Market Share in Volume by Country (2017-2022)
  • Table 68. North America Polymerases Sales by Country (2017-2022) & (US$ Million)
  • Table 69. North America Polymerases Sales Market Share in Value by Country (2017-2022)
  • Table 70. North America Polymerases Sales by Country (2023-2028) & (M Units)
  • Table 71. North America Polymerases Sales Market Share in Volume by Country (2023-2028)
  • Table 72. North America Polymerases Sales by Country (2023-2028) & (US$ Million)
  • Table 73. North America Polymerases Sales Market Share in Value by Country (2023-2028)
  • Table 74. Europe Polymerases Sales by Country (2017-2022) & (M Units)
  • Table 75. Europe Polymerases Sales Market Share in Volume by Country (2017-2022)
  • Table 76. Europe Polymerases Sales by Country (2017-2022) & (US$ Million)
  • Table 77. Europe Polymerases Sales Market Share in Value by Country (2017-2022)
  • Table 78. Europe Polymerases Sales by Country (2023-2028) & (M Units)
  • Table 79. Europe Polymerases Sales Market Share in Volume by Country (2023-2028)
  • Table 80. Europe Polymerases Sales by Country (2023-2028) & (US$ Million)
  • Table 81. Europe Polymerases Sales Market Share in Value by Country (2023-2028)
  • Table 82. Asia-Pacific Polymerases Sales by Region (2017-2022) & (M Units)
  • Table 83. Asia-Pacific Polymerases Sales Market Share in Volume by Region (2017-2022)
  • Table 84. Asia-Pacific Polymerases Sales by Region (2017-2022) & (US$ Million)
  • Table 85. Asia-Pacific Polymerases Sales Market Share in Value by Region (2017-2022)
  • Table 86. Asia-Pacific Polymerases Sales by Region (2023-2028) & (M Units)
  • Table 87. Asia-Pacific Polymerases Sales Market Share in Volume by Region (2023-2028)
  • Table 88. Asia-Pacific Polymerases Sales by Region (2023-2028) & (US$ Million)
  • Table 89. Asia-Pacific Polymerases Sales Market Share in Value by Region (2023-2028)
  • Table 90. Latin America Polymerases Sales by Country (2017-2022) & (M Units)
  • Table 91. Latin America Polymerases Sales Market Share in Volume by Country (2017-2022)
  • Table 92. Latin America Polymerases Sales by Country (2017-2022) & (US$ Million)
  • Table 93. Latin America Polymerases Sales Market Share in Value by Country (2017-2022)
  • Table 94. Latin America Polymerases Sales by Country (2023-2028) & (M Units)
  • Table 95. Latin America Polymerases Sales Market Share in Volume by Country (2023-2028)
  • Table 96. Latin America Polymerases Sales by Country (2023-2028) & (US$ Million)
  • Table 97. Latin America Polymerases Sales Market Share in Value by Country (2023-2028)
  • Table 98. Middle East and Africa Polymerases Sales by Country (2017-2022) & (M Units)
  • Table 99. Middle East and Africa Polymerases Sales Market Share in Volume by Country (2017-2022)
  • Table 100. Middle East and Africa Polymerases Sales by Country (2017-2022) & (US$ Million)
  • Table 101. Middle East and Africa Polymerases Sales Market Share in Value by Country (2017-2022)
  • Table 102. Middle East and Africa Polymerases Sales by Country (2023-2028) & (M Units)
  • Table 103. Middle East and Africa Polymerases Sales Market Share by Country (2023-2028)
  • Table 104. Middle East and Africa Polymerases Sales by Country (2023-2028) & (US$ Million)
  • Table 105. Middle East and Africa Polymerases Sales Market Share in Value by Country (2023-2028)
  • Table 106. Thermo Fisher Scientific Corporation Information
  • Table 107. Thermo Fisher Scientific Introduction and Business Overview
  • Table 108. Thermo Fisher Scientific Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 109. Thermo Fisher Scientific Polymerases Product
  • Table 110. Thermo Fisher Scientific Recent Development
  • Table 111. Merck Corporation Information
  • Table 112. Merck Introduction and Business Overview
  • Table 113. Merck Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 114. Merck Polymerases Product
  • Table 115. Merck Recent Development
  • Table 116. New England Biolabs Corporation Information
  • Table 117. New England Biolabs Introduction and Business Overview
  • Table 118. New England Biolabs Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 119. New England Biolabs Polymerases Product
  • Table 120. New England Biolabs Recent Development
  • Table 121. Promega Corporation Information
  • Table 122. Promega Introduction and Business Overview
  • Table 123. Promega Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 124. Promega Polymerases Product
  • Table 125. Ampliqon Corporation Information
  • Table 126. Ampliqon Introduction and Business Overview
  • Table 127. Ampliqon Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 128. Ampliqon Polymerases Product
  • Table 129. Agilent Technologies Corporation Information
  • Table 130. Agilent Technologies Introduction and Business Overview
  • Table 131. Agilent Technologies Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 132. Agilent Technologies Polymerases Product
  • Table 133. Agilent Technologies Recent Development
  • Table 134. F. Hoffmann-la Roche Corporation Information
  • Table 135. F. Hoffmann-la Roche Introduction and Business Overview
  • Table 136. F. Hoffmann-la Roche Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 137. F. Hoffmann-la Roche Polymerases Product
  • Table 138. F. Hoffmann-la Roche Recent Development
  • Table 139. Takara Bio Corporation Information
  • Table 140. Takara Bio Introduction and Business Overview
  • Table 141. Takara Bio Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 142. Takara Bio Polymerases Product
  • Table 143. QIAGEN N.V. Corporation Information
  • Table 144. QIAGEN N.V. Introduction and Business Overview
  • Table 145. QIAGEN N.V. Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 146. QIAGEN N.V. Polymerases Product
  • Table 147. BioChain Institute Corporation Information
  • Table 148. BioChain Institute Introduction and Business Overview
  • Table 149. BioChain Institute Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 150. BioChain Institute Polymerases Product
  • Table 151. Enzo Biochem Corporation Information
  • Table 152. Enzo Biochem Introduction and Business Overview
  • Table 153. Enzo Biochem Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 154. Enzo Biochem Polymerases Product
  • Table 155. Abbexa Corporation Information
  • Table 156. Abbexa Introduction and Business Overview
  • Table 157. Abbexa Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 158. Abbexa Polymerases Product
  • Table 159. Bioneer Corporation Information
  • Table 160. Bioneer Introduction and Business Overview
  • Table 161. Bioneer Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 162. Bioneer Polymerases Product
  • Table 163. Kaneka Corporation Information
  • Table 164. Kaneka Introduction and Business Overview
  • Table 165. Kaneka Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 166. Kaneka Polymerases Product
  • Table 167. NIPPON GENE Corporation Information
  • Table 168. NIPPON GENE Introduction and Business Overview
  • Table 169. NIPPON GENE Polymerases Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 170. NIPPON GENE Polymerases Product
  • Table 171. Raw Materials Key Suppliers Lists
  • Table 172. Polymerases Distributors List
  • Table 173. Polymerases Downstream Customers
  • Table 174. Research Programs/Design for This Report
  • Table 175. Key Data Information from Secondary Sources
  • Table 176. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Polymerases Product Picture
  • Figure 2. Global Polymerases Market Size, 2017 VS 2021 VS 2028 (US$ Million)
  • Figure 3. Global Polymerases Market Size Status and Outlook (2017-2028) & (US$ Million)
  • Figure 4. Global Polymerases Sales Status and Outlook (2017-2028) & (M Units)
  • Figure 5. Product Picture of DNA Polymerases
  • Figure 6. Global DNA Polymerases Sales YoY Growth (2017-2028) & (M Units)
  • Figure 7. Product Picture of RNA Polymerases
  • Figure 8. Global RNA Polymerases Sales YoY Growth (2017-2028) & (M Units)
  • Figure 9. Global Polymerases Sales by Type (2017-2028) & (US$ Million)
  • Figure 10. Global Polymerases Market Share by Type in 2021 & 2028
  • Figure 11. North America Polymerases Sales Market Share in Volume by Type in 2021
  • Figure 12. North America Polymerases Sales Market Share in Value by Type in 2021
  • Figure 13. Europe Polymerases Sales Market Share in Volume by Type in 2021
  • Figure 14. Europe Polymerases Sales Market Share in Value by Type in 2021
  • Figure 15. Asia-Pacific Polymerases Sales Market Share in Volume by Type in 2021
  • Figure 16. Asia-Pacific Polymerases Sales Market Share in Value by Type in 2021
  • Figure 17. Latin America Polymerases Sales Market Share in Volume by Type in 2021
  • Figure 18. Latin America Polymerases Sales Market Share in Value by Type in 2021
  • Figure 19. Middle East and Africa Polymerases Sales Market Share in Volume by Type in 2021
  • Figure 20. Middle East and Africa Polymerases Sales Market Share in Value by Type in 2021
  • Figure 21. The 3 and 5 Largest Manufacturers in the World: Market Share by Polymerases Sales in 2021
  • Figure 22. The 3 and 5 Largest Manufacturers in the World: Market Share by Polymerases Revenue in 2021
  • Figure 23. Polymerases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 24. Product Picture of Academic & Research Institutes
  • Figure 25. Global Academic & Research Institutes Sales YoY Growth (2017-2028) & (M Units)
  • Figure 26. Product Picture of Hospitals & Diagnostic Centers
  • Figure 27. Global Hospitals & Diagnostic Centers Sales YoY Growth (2017-2028) & (M Units)
  • Figure 28. Product Picture of Pharmaceutical & Biotechnology Companies
  • Figure 29. Global Pharmaceutical & Biotechnology Companies Sales YoY Growth (2017-2028) & (M Units)
  • Figure 30. Global Polymerases Sales by Application (2017-2028) & (US$ Million)
  • Figure 31. Global Polymerases Market Share by Application in 2021 & 2028
  • Figure 32. North America Polymerases Sales Market Share in Volume by Application in 2021
  • Figure 33. North America Polymerases Sales Market Share in Value by Application in 2021
  • Figure 34. Europe Polymerases Sales Market Share in Volume by Application in 2021
  • Figure 35. Europe Polymerases Sales Market Share in Value by Application in 2021
  • Figure 36. Asia-Pacific Polymerases Sales Market Share in Volume by Application in 2021
  • Figure 37. Asia-Pacific Polymerases Sales Market Share in Value by Application in 2021
  • Figure 38. Latin America Polymerases Sales Market Share in Volume by Application in 2021
  • Figure 39. Latin America Polymerases Sales Market Share in Value by Application in 2021
  • Figure 40. Middle East and Africa Polymerases Sales Market Share in Volume by Application in 2021
  • Figure 41. Middle East and Africa Polymerases Sales Market Share in Value by Application in 2021
  • Figure 42. Polymerases Manufacturing Cost Structure
  • Figure 43. Polymerases Industrial Chain Analysis
  • Figure 44. Channels of Distribution
  • Figure 45. Distributors Profiles
  • Figure 46. Bottom-up and Top-down Approaches for This Report
  • Figure 47. Data Triangulation
  • Figure 48. Key Executives Interviewed